Search hospitals > California > Loma Linda
Loma Linda University Cancer Institute at Loma Linda University Medical Center
Claim this profileLoma Linda, California 92354
Global Leader in Leukemia
Global Leader in Breast Cancer
Conducts research for Brain Tumor
Conducts research for Tumors
Conducts research for Lymphoma
100 reported clinical trials
6 medical researchers
Summary
Loma Linda University Cancer Institute at Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Leukemia, Breast Cancer, Brain Tumor, Tumors, Lymphoma and other specialties. Loma Linda University Cancer Institute at Loma Linda University Medical Center is involved with conducting 100 clinical trials across 102 conditions. There are 6 research doctors associated with this hospital, such as Albert Kheradpour, Gayathri Nagaraj, Yevgeniya Ioffe, MD, and Hisham Abdel-Azim, MD.Area of expertise
1Leukemia
Global LeaderFLT3 positive
2Breast Cancer
Global LeaderHER2 negative
Stage II
Stage I
Top PIs
Albert KheradpourLoma Linda University Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
54 reported clinical trials
104 drugs studied
Gayathri NagarajLoma Linda University Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Allergy
4 reported clinical trials
11 drugs studied
Yevgeniya Ioffe, MDLoma Linda University Medical Center7 years of reported clinical research
Studies Ovarian Cancer
Studies Adenocarcinoma
4 reported clinical trials
12 drugs studied
Hisham Abdel-Azim, MDChildren's Hospital of Los Angeles5 years of reported clinical research
Studies Quality of Life
Studies Leukemia
4 reported clinical trials
5 drugs studied
Clinical Trials running at Loma Linda University Cancer Institute at Loma Linda University Medical Center
Breast Cancer
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Lymphoma
Lymphoma
Acute Myeloid Leukemia
Allergy
Allergic Reaction
Large B-Cell Lymphoma
Leukemia
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Evexomostat + Alpelisib + Fulvestrant
for Breast Cancer
This trial tests a new drug combination for post-menopausal women with a specific type of advanced breast cancer. It aims to see if the new drug can reduce side effects and improve the effectiveness of existing treatments. The treatment works by blocking proteins and hormones that help cancer grow and by managing side effects like high blood sugar.
Recruiting1 award Phase 1 & 211 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Loma Linda University Cancer Institute at Loma Linda University Medical Center?
Loma Linda University Cancer Institute at Loma Linda University Medical Center is a medical facility located in Loma Linda, California. This center is recognized for care of Leukemia, Breast Cancer, Brain Tumor, Tumors, Lymphoma and other specialties. Loma Linda University Cancer Institute at Loma Linda University Medical Center is involved with conducting 100 clinical trials across 102 conditions. There are 6 research doctors associated with this hospital, such as Albert Kheradpour, Gayathri Nagaraj, Yevgeniya Ioffe, MD, and Hisham Abdel-Azim, MD.